Rexulti (Brexpiprazole) Approved For Schizophrenia & Depression (Adjunct)
Rexulti (Brexpiprazole) is a drug that was approved July 10, 2015 for the treatment of schizophrenia and as an adjunctive option for major depressive disorder. In clinical trials it was refe…
Read article